Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-01

Clinical Trial Update: Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis

View source ↗

Summary

This completed study in multiple sclerosis evaluates eye-tracking metrics as potential clinical measures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Innodem Neurosciences | Conditions: Multiple Sclerosis | Status: COMPLETED